Barometer Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Barometer Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74M	Buy	11,000 +7,800	+244%	+$1.05M	0.48%	47
2026 Q1	$409K	Buy	+3,200	New	+$399K	0.14%	101
2024 Q2	–	Sell	-4,800	Closed	-$406K	–	238
2024 Q1	$406K	Buy	+4,800	New	+$445K	0.11%	104
2023 Q1	–	Sell	-6,000	Closed	-$498K	–	168
2022 Q4	$498K	Buy	6,000 +200	+3%	+$16.2K	0.15%	88
2022 Q3	$460K	Buy	5,800 +1,400	+32%	+$118K	0.19%	55
2022 Q2	$395K	Buy	+4,400	New	+$330K	0.16%	60
2021 Q2	–	Sell	-3,530	Closed	-$479K	–	180
2021 Q1	$479K	Sell	3,530 -2,370	-40%	-$355K	0.08%	132
2020 Q4	$831K	Buy	5,900 +2,370	+67%	+$304K	0.16%	106
2020 Q3	$393K	Sell	3,530 -8,000	-69%	-$897K	0.08%	118
2020 Q2	$1.29M	Buy	11,530 +4,830	+72%	+$476K	0.24%	88
2020 Q1	$519K	Sell	6,700 -4,200	-39%	-$372K	0.15%	71
2019 Q4	$1.04M	Buy	+10,900	New	+$943K	0.16%	98
2019 Q2	–	Sell	-40,600	Closed	-$3.68M	–	174
2019 Q1	$3.68M	Buy	+40,600	New	+$3.45M	0.42%	80
2018 Q3	–	Sell	-84,400	Closed	-$8.03M	–	181
2018 Q2	$8.03M	Buy	84,400 +12,500	+17%	+$1.15M	0.67%	45
2018 Q1	$6.31M	Buy	+71,900	New	+$6.56M	0.53%	59
2017 Q4	–	Sell	-48,100	Closed	-$4.16M	–	173
2017 Q3	$4.16M	Buy	48,100 +300	+0.6%	+$24.1K	0.4%	80
2017 Q2	$3.69M	Buy	47,800 +3,000	+7%	+$213K	0.37%	81
2017 Q1	$3.11M	Buy	+44,800	New	+$3.01M	0.27%	69
2016 Q4	–	Sell	-41,200	Closed	-$2.73M	–	182
2016 Q3	$2.73M	Buy	+41,200	New	+$2.55M	0.3%	78
2015 Q4	–	Sell	-24,300	Closed	-$1.51M	–	159
2015 Q3	$1.51M	Buy	+24,300	New	+$1.91M	0.19%	68

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Barometer Capital Management's XBI Position: Q2 2026 in Review

Barometer Capital Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 244% in Q2 2026, buying an estimated $1.05M and bringing the position to 11,000 shares worth $1.74M. The position accounts for 0.48% of the portfolio, ranked #47.

Barometer Capital Management first reported a position in XBI in Q3 2015 and has held it in 20 quarters since. The position peaked at $8.03M in Q2 2018. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Barometer Capital Management held 11,000 shares of State Street SPDR S&P Biotech ETF worth $1.74M as of Q2 2026.
Barometer Capital Management bought 7,800 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.05M.
State Street SPDR S&P Biotech ETF made up 0.48% of Barometer Capital Management's portfolio in Q2 2026, its #47 holding.
Barometer Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2015 and has held it in 20 quarters since.
Barometer Capital Management's State Street SPDR S&P Biotech ETF position peaked at $8.03M in Q2 2018.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Barometer Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.